Compare STEM & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STEM | TKNO |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 308.3M |
| IPO Year | 2020 | 2021 |
| Metric | STEM | TKNO |
|---|---|---|
| Price | $5.37 | $4.91 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.33 | N/A |
| AVG Volume (30 Days) | 102.4K | ★ 115.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $156,266,000.00 | $40,520,000.00 |
| Revenue This Year | $2.77 | $8.27 |
| Revenue Next Year | $14.65 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.08 | 7.35 |
| 52 Week Low | $4.92 | $1.91 |
| 52 Week High | $32.23 | $6.68 |
| Indicator | STEM | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 34.12 | 44.37 |
| Support Level | N/A | $4.09 |
| Resistance Level | $8.39 | $4.94 |
| Average True Range (ATR) | 0.38 | 0.36 |
| MACD | -0.04 | -0.08 |
| Stochastic Oscillator | 27.27 | 18.56 |
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.